ROCK CREEK PHARMACEUTICALS, INC.
CIK 0000776008
Revenue (TTM)
—
Q2 Aug 2016
Net Income (TTM)
−$9.17M
−15.3% YoY
Q2 Aug 2016
EPS Diluted (TTM)
—
Q2 Aug 2016
Gross Margin
—
Q2 Aug 2016
Operating Margin
—
Q2 Aug 2016
Net Margin
—
Q2 Aug 2016
Free Cash Flow (TTM)
−$17.79M
Q2 Aug 2016
Cash
$185K
Q2 Aug 2016
Total Debt
$15.09M
Q2 Aug 2016
Shares Outstanding
170.44M sh
Q2 Aug 2016
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.